139 related articles for article (PubMed ID: 35388801)
1. Development of hypothyroidism over 13 years of follow-up of patients with hyperthyroidism after radioiodine therapy.
Li JF; Xie LJ; Qin LP; Wan QC; Li JP; Wu QY; Cheng MH
Hell J Nucl Med; 2022; 25(1):26-31. PubMed ID: 35388801
[TBL] [Abstract][Full Text] [Related]
2. Long-term follow-up study of radioiodine treatment of hyperthyroidism.
Metso S; Jaatinen P; Huhtala H; Luukkaala T; Oksala H; Salmi J
Clin Endocrinol (Oxf); 2004 Nov; 61(5):641-8. PubMed ID: 15521969
[TBL] [Abstract][Full Text] [Related]
3. Cohort study on radioactive iodine-induced hypothyroidism: implications for Graves' ophthalmopathy and optimal timing for thyroid hormone assessment.
Stan MN; Durski JM; Brito JP; Bhagra S; Thapa P; Bahn RS
Thyroid; 2013 May; 23(5):620-5. PubMed ID: 23205939
[TBL] [Abstract][Full Text] [Related]
4. Radioiodine treatment of hyperthyroidism: prognostic factors affecting outcome.
Erem C; Kandemir N; Hacihasanoglu A; Ersöz HO; Ukinc K; Kocak M
Endocrine; 2004 Oct; 25(1):55-60. PubMed ID: 15545707
[TBL] [Abstract][Full Text] [Related]
5. Treatment of post-radioactive iodine relapse of hyperthyroidism: comparison of long-term methimazole and radioactive iodine treatment.
Saadat N; Azizi F; Abdi H; Amouzegar A
J Endocrinol Invest; 2022 Oct; 45(10):1919-1924. PubMed ID: 35610532
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of hyperthyroidism caused by Graves' disease or toxic multinodular goitre by radioiodine: over 80% cure retrospectively after one calculated dose].
Bakker SC; Zanin DE; Zweers EJ
Ned Tijdschr Geneeskd; 2002 Sep; 146(39):1837-41. PubMed ID: 12382370
[TBL] [Abstract][Full Text] [Related]
7. Prediction of cure and risk of hypothyroidism in patients receiving 131I for hyperthyroidism.
Boelaert K; Syed AA; Manji N; Sheppard MC; Holder RL; Gough SC; Franklyn JA
Clin Endocrinol (Oxf); 2009 Jan; 70(1):129-38. PubMed ID: 18462261
[TBL] [Abstract][Full Text] [Related]
8. Radioactive iodine therapy for pediatric Graves' disease: a single-center experience over a 10-year period.
Kaplowitz PB; Jiang J; Vaidyanathan P
J Pediatr Endocrinol Metab; 2020 Mar; 33(3):383-389. PubMed ID: 31603857
[TBL] [Abstract][Full Text] [Related]
9. Thyroid function and mortality in patients treated for hyperthyroidism.
Franklyn JA; Sheppard MC; Maisonneuve P
JAMA; 2005 Jul; 294(1):71-80. PubMed ID: 15998893
[TBL] [Abstract][Full Text] [Related]
10. Predictors of Hypothyroidism Following Empirical Dose Radioiodine in Toxic Thyroid Nodules: Real-Life Experience.
Demir BK; Karakilic E; Saygili ES; Araci N; Ozdemir S
Endocr Pract; 2022 Aug; 28(8):749-753. PubMed ID: 35537668
[TBL] [Abstract][Full Text] [Related]
11. The incidence of recurrence and hypothyroidism after radioiodine treatment in patients with hyperthyroidism in Trakya, a mild iodine deficiency area, during the period 1991-2003.
Ustun F; Yuksel M; Durmus-Altun G; Kaya M; Cermik TF; Sarikaya A; Berkarda S
Ann Nucl Med; 2005 Dec; 19(8):737-42. PubMed ID: 16445003
[TBL] [Abstract][Full Text] [Related]
12. The Presence of Anti-TPO Antibodies Increase the Likelihood of Post-I131 Hypothyroidism.
Quataert F; Bravenboer B; Keyaerts M; Andreescu CE
Horm Metab Res; 2024 Feb; 56(2):134-141. PubMed ID: 37931916
[TBL] [Abstract][Full Text] [Related]
13. Radioiodine treatment of hyperthyroidism. Success rate and influence of thyrostatic medication.
Ghadban WK; Zirie MA; Al-Khateeb DA; Jayyousi AA; Mobayedh HM; El-Aloosy AS
Saudi Med J; 2003 Apr; 24(4):347-51. PubMed ID: 12754531
[TBL] [Abstract][Full Text] [Related]
14. Cure Rates After a Single Dose of Radioactive Iodine to Treat Hyperthyroidism: The Fixed-Dose Regimen.
Madu NM; Skinner C; Oyibo SO
Cureus; 2022 Aug; 14(8):e28316. PubMed ID: 36039121
[TBL] [Abstract][Full Text] [Related]
15. [Radioiodine therapy in thyroid autonomy: initial results and experiences].
Bajner A
Orv Hetil; 2008 May; 149(18):839-42. PubMed ID: 18436512
[TBL] [Abstract][Full Text] [Related]
16. Serum thyroid autoantibodies as a risk factor for development of hypothyroidism after radioactive iodine therapy for single thyroid 'hot' nodule.
Mariotti S; Martino E; Francesconi M; Ceccarelli C; Grasso L; Lippi F; Baschieri L; Pinchera A
Acta Endocrinol (Copenh); 1986 Dec; 113(4):500-7. PubMed ID: 3788420
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of radioiodine (131-I) as definitive therapy in patients with autoimmune and non-autoimmune hyperthyroidism.
Tarantini B; Ciuoli C; Di Cairano G; Guarino E; Mazzucato P; Montanaro A; Burroni L; Vattimo AG; Pacini F
J Endocrinol Invest; 2006; 29(7):594-8. PubMed ID: 16957406
[TBL] [Abstract][Full Text] [Related]
18. Radioiodine treatment of hyperthyroidism-prognostic factors for outcome.
Allahabadia A; Daykin J; Sheppard MC; Gough SC; Franklyn JA
J Clin Endocrinol Metab; 2001 Aug; 86(8):3611-7. PubMed ID: 11502786
[TBL] [Abstract][Full Text] [Related]
19. Cancer Risk After Radioactive Iodine Treatment for Hyperthyroidism: A Cohort Study.
Gronich N; Lavi I; Rennert G; Saliba W
Thyroid; 2020 Feb; 30(2):243-250. PubMed ID: 31880205
[No Abstract] [Full Text] [Related]
20. Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism.
Franklyn JA; Daykin J; Holder R; Sheppard MC
QJM; 1995 Mar; 88(3):175-80. PubMed ID: 7767667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
